The U.S. dollar's sharp decline in 2025 is hitting American travelers hard, raising vacation costs in Paris, London, Cancun, ...

Novo Nordisk executives overlooked warnings ahead of Wegovy's launch, leading to supply issues, high costs, and challenges competing with Eli Lilly's Zepbound.

It was reported on July 1, that Christopher Harborne, 10% Owner at Innovative Solns ISSC -1.01% Get Free Report executed a significant insider sell, according to an SEC filing.

What Happened: Cox's recent move involves selling 68,590 shares of Hewlett Packard. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Most stablecoins in circulation today, such as USDC and USDT, are fiat-backed and centrally issued. While this has helped with mainstream adoption, it also anchors them to legacy systems—custodial ...

What Happened: According to a Form 4 filing with the U.S. Securities and Exchange Commission on Monday, Tan sold 40,000 shares of Broadcom. The total transaction value is $10,731,720. Tracking the ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $250.0 to $380.0 for Constellation Energy over the last 3 months.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 39 extraordinary options activities for Intuit. This level of activity is out of the ordinary. The ...

What Happened: In a recent Form 4 filing with the U.S. Securities and Exchange Commission on Monday, Mazzacco, Director at Krystal Biotech, acquired 5,000 stock options for KRYS with an exercise price ...

What Happened: Disclosed in a Form 4 filing on Monday with the U.S. Securities and Exchange Commission, Sutherland, Board Member at Krystal Biotech, executed a strategic derivative sale. This involved ...

Krystal Biotech shares are trading, exhibiting down of 0.0% and priced at $137.46 during Tuesday's morning. This values Janney's 0 shares at $0.